Minimum 8 years of experience in healthcare, biotech, or related sales roles., Strong background in account management, sales, or reimbursement within the pharmaceutical industry., Experience with rare diseases or neuromuscular conditions is preferred., Excellent communication and relationship-building skills with healthcare providers and stakeholders..
Key responsibilities:
Develop and execute territory strategies to promote SMA treatments and achieve sales targets.
Educate healthcare providers about SMA and Scholar Rock's therapies to facilitate treatment decisions.
Build and maintain relationships with physicians and healthcare stakeholders through tailored engagement and support.
Collaborate with internal teams and external stakeholders to ensure access and logistics for patient care.
Report this Job
Help us maintain the quality of our job listings. If you find any issues
with this job post, please let us know. Select the reason you're reporting
this job:
Born from social and inspired by culture, we’re champions of storytelling across the platforms and technologies that shape the internet; today and tomorrow.
We work with global brands to connect the dots in a maze of swipe, tap, forgettable.
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers lifechanging therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinicalstage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factortargeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscletargeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cuttingedge science in disease spaces that are historically underaddressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.